Cancer Drug Encyclopedia

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

Approved for use in oncology care according to FDA-approved indications.

HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.

Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.

Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.

Adjuvant and neoadjuvant therapy for node-positive and high-risk early Breast Cancer.

First-line and second-line therapy for Metastatic Colorectal Cancer, Gastric Cancer, and Esophageal Adenocarcinoma.

First-line treatment of Metastatic Colorectal Cancer.

First-line treatment of KRAS/NRAS Wild-Type Metastatic Colorectal Cancer.

First-line treatment for Metastatic and Locally Advanced Pancreatic Adenocarcinoma, and advanced Colorectal Cancer.

Stage III Colon Cancer adjuvant therapy, Metastatic Colorectal Cancer, and Gastroesophageal Adenocarcinoma.

Colorectal Cancer, Gastric Cancer, and Pancreatic Cancer.